#1 Clinical Trials Search in Europe

Methylprednisolone Sodium Succinate

Methylprednisolone sodium succinate is a corticosteroid medication being studied in various clinical trials for its potential benefits in treating different medical conditions. This article examines the use of this drug in clinical trials for conditions ranging from alopecia and stroke to respiratory distress syndrome and knee osteoarthritis. We’ll explore how researchers are investigating its efficacy, safety, and potential to improve patient outcomes across diverse medical scenarios.

Table of Contents

What is Methylprednisolone Sodium Succinate?

Methylprednisolone Sodium Succinate is a type of corticosteroid medication. Corticosteroids are synthetic drugs that mimic the effects of hormones naturally produced by your adrenal glands. This medication is known by several other names, including:

  • A-MethaPred
  • Asmacortone
  • Cryosolona
  • Medrate
  • Metypred
  • Prednilem
  • Solu Moderin
  • Solu-Medrol
  • Solu-Medrone
These alternative names may be used in different countries or by different manufacturers[3].

Medical Conditions Treated

Methylprednisolone Sodium Succinate is used to treat a wide range of medical conditions due to its potent anti-inflammatory and immunosuppressive properties. Some of the conditions it’s used for include:

  • Severe Alopecia Areata: A condition causing hair loss[1]
  • Acute Ischemic Stroke: A type of stroke caused by a blockage in blood flow to the brain[2]
  • Acute Graft-versus-Host Disease (GVHD): A complication that can occur after a bone marrow or stem cell transplant[3]
  • Severe Acute Respiratory Syndrome (SARS): Including SARS caused by COVID-19[4]
  • Community-acquired Pneumonia: Lung infection acquired outside of healthcare settings[5]
  • Acute Respiratory Distress Syndrome (ARDS): A severe lung condition that causes breathing difficulties[6]
  • Severe Asthma: A chronic lung disease causing breathing difficulties[7]

How It Works

Methylprednisolone Sodium Succinate works by reducing inflammation and suppressing the immune system. It does this in several ways:

  • Decreasing the production of inflammatory substances in the body
  • Reducing the activity of certain immune cells
  • Preventing the release of substances that cause allergic reactions

In some conditions, like severe asthma, it helps to relax airways and make breathing easier. In cases of severe inflammation, such as in ARDS or severe COVID-19, it can help reduce the harmful effects of an overactive immune response[4][6].

How It’s Administered

Methylprednisolone Sodium Succinate is typically administered in one of the following ways:

  • Intravenous (IV) injection: The medication is injected directly into a vein. This is common in hospital settings for acute conditions[2].
  • Oral tablets: In some cases, it may be given as tablets to be taken by mouth[1].
  • Intra-arterial injection: In specific cases, like certain types of GVHD, it may be injected directly into an artery[3].

The dosage and duration of treatment can vary widely depending on the condition being treated and the individual patient’s response. Always follow your doctor’s instructions carefully when taking this medication.

Current Clinical Trials

Methylprednisolone Sodium Succinate is currently being studied in several clinical trials for various conditions:

  • Treatment of severe alopecia areata[1]
  • As an adjunctive treatment for acute ischemic stroke[2]
  • Management of severe COVID-19 and SARS[4]
  • Treatment of community-acquired pneumonia[5]
  • Pain management after total knee replacement surgery[8]

These trials aim to better understand the effectiveness and optimal use of the medication in these conditions.

Potential Side Effects

Like all medications, Methylprednisolone Sodium Succinate can cause side effects. Some potential side effects include:

  • Increased blood sugar levels (hyperglycemia)
  • Changes in electrolyte levels, particularly potassium
  • Increased risk of infections
  • Changes in mood or behavior
  • Fluid retention
  • Increased blood pressure

In clinical trials, researchers carefully monitor for these and other potential side effects[1][2]. It’s important to discuss potential risks and benefits with your healthcare provider before starting treatment with this medication.

Condition Study Type Administration Method Key Outcomes Measured
Alopecia Areata Randomized, single-center Oral pulse treatment Hair regrowth, safety
Acute Ischemic Stroke Randomized, double-blind, placebo-controlled Intravenous injection Mortality, intracranial hemorrhage
Acute Respiratory Distress Syndrome Prospective phase II Intravenous Mortality, ventilator-free days
Ocular Graft-Versus-Host Disease Randomized, comparative Topical eye drops Ocular symptoms, safety
Community-Acquired Pneumonia Randomized, double-blind, placebo-controlled Intravenous Mortality, ICU admission, hospital stay
Knee Osteoarthritis (post-surgery) Randomized, double-blind, placebo-controlled Single intravenous dose pre-operation Post-operative pain, recovery time

FAQ

  • What is methylprednisolone sodium succinate? Methylprednisolone sodium succinate is a corticosteroid medication that reduces inflammation and suppresses the immune system. It's being studied in various clinical trials for its potential benefits in treating different medical conditions.
  • In which medical conditions is methylprednisolone sodium succinate being studied? The drug is being studied in clinical trials for conditions such as alopecia areata, acute ischemic stroke, acute respiratory distress syndrome, ocular graft-versus-host disease, community-acquired pneumonia, and post-operative pain management in knee replacement surgery.
  • How is methylprednisolone sodium succinate administered in these trials? The administration method varies depending on the study. It may be given orally, intravenously, intra-arterially, or topically. The dosage and frequency also differ based on the specific condition being treated and the study protocol.
  • What are some potential benefits of methylprednisolone sodium succinate being investigated? Researchers are exploring its potential to reduce inflammation, improve pain management, enhance recovery after surgery, reduce mortality in severe conditions, and improve outcomes in various diseases such as alopecia areata and acute respiratory distress syndrome.
  • Are there any side effects or risks associated with methylprednisolone sodium succinate use in these trials? While specific side effects may vary depending on the condition and dosage, common concerns include monitoring for adverse events, potential impacts on blood sugar levels, and effects on the immune system. Each trial includes safety monitoring to assess potential risks and side effects.

Ongoing Clinical Trials on Methylprednisolone Sodium Succinate

  • Study for Adults with Very High-Risk T-Cell Acute Lymphoblastic Leukemia Using Daratumumab and a Drug Combination

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Italy

  • Study on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated drugs:
    Belgium Bulgaria Croatia France Italy Poland +3

  • Study on the Safety and Effectiveness of Ocrelizumab vs. Fingolimod for Children and Adolescents with Relapsing-Remitting Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated drugs:
    Austria Belgium Bulgaria Croatia Denmark Estonia +11

  • Study on Zetomipzomib for Patients with Active Lupus Nephritis

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Croatia France Germany Greece Italy Portugal +1

  • Study of Obinutuzumab for Patients with Primary Membranous Nephropathy Resistant or Intolerant to Rituximab

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Italy

Glossary

  • Alopecia areata: An autoimmune disorder causing hair loss in patches on the scalp or body.
  • Acute ischemic stroke: A sudden interruption in the blood supply to the brain, typically caused by a blood clot.
  • Acute respiratory distress syndrome (ARDS): A severe lung condition characterized by rapid onset of widespread inflammation in the lungs.
  • Graft-versus-host disease (GVHD): A complication that can occur after a bone marrow or stem cell transplant where the donor cells attack the recipient's tissues.
  • Corticosteroid: A class of steroid hormones produced in the adrenal cortex or made synthetically, often used to reduce inflammation.
  • Intra-arterial: Administered directly into an artery.
  • Endovascular treatment: A minimally invasive procedure performed inside the blood vessels.
  • Placebo: An inactive substance or treatment used in clinical trials as a control to compare with the active drug or treatment being tested.
  • Randomized controlled trial: A type of scientific experiment where participants are randomly assigned to different treatment groups to compare outcomes.
  • Visual analogue scale (VAS): A measurement instrument used to assess subjective characteristics or attitudes that cannot be directly measured.

References

  1. https://clinicaltrials.gov/study/NCT01167946
  2. https://clinicaltrials.gov/study/NCT06360458
  3. https://clinicaltrials.gov/study/NCT02425813
  4. https://clinicaltrials.gov/study/NCT04343729
  5. https://clinicaltrials.gov/study/NCT04007328
  6. https://clinicaltrials.gov/study/NCT00290602
  7. https://clinicaltrials.gov/study/NCT06171932
  8. https://clinicaltrials.gov/study/NCT03082092